PP
LUNG icon

PDT Partners’s Pulmonx LUNG Stock Holding History

PDT Partners’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37,815
Closed -$97.9K – 662
2025
Q2 		$97.9K Sell
37,815
-33,822
-47% -$133K 0.01% 670
2025
Q1 		$482K Buy
71,637
+22,259
+45% +$158K 0.03% 532
2024
Q4 		$335K Sell
49,378
-38,696
-44% -$255K 0.03% 551
2024
Q3 		$730K Buy
88,074
+17,784
+25% +$129K 0.06% 433
2024
Q2 		$446K Hold
70,290
– – 0.04% 490
2024
Q1 		$652K Buy
70,290
+38,693
+122% +$454K 0.06% 409
2023
Q4 		$403K Buy
31,597
+36
+0.1% +$375 0.04% 430
2023
Q3 		$326K Sell
31,561
-8
-0% -$93 0.04% 462
2023
Q2 		$414K Sell
31,569
-24,352
-44% -$298K 0.06% 408
2023
Q1 		$625K Sell
55,921
-17,841
-24% -$176K 0.08% 354
2022
Q4 		$622K Buy
73,762
+12,380
+20% +$118K 0.1% 342
2022
Q3 		$1.02M Sell
61,382
-5,985
-9% -$110K 0.15% 212
2022
Q2 		$992K Buy
67,367
+53,142
+374% +$1.09M 0.09% 397
2022
Q1 		$353K Buy
+14,225
New +$367K 0.03% 673
2021
Q2 		– Sell
-4,788
Closed -$219K – 898
2021
Q1 		$219K Buy
+4,788
New +$275K 0.02% 689

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PDT Partners's LUNG Position: Q3 2025 in Review

PDT Partners sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 37,815 shares — an estimated $97.9K sold.

PDT Partners first reported a position in LUNG in Q1 2021 and held it in 15 quarters. The position peaked at $1.02M in Q3 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

  • PDT Partners reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 37,815 Pulmonx shares in Q3 2025, an estimated $97.9K.
  • PDT Partners first reported a position in Pulmonx in Q1 2021 and held it in 15 quarters.
  • PDT Partners's Pulmonx position peaked at $1.02M in Q3 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.